Cited by 5,204Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesDiet and metabolism studies

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Early Identification of Refractory Epilepsy

Open access

Kwan, Patrick, Brodie, Martin J.·2000·New England Journal of Medicine

DOI 10.1056/nejm200002033420503

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures. METHODS: We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year. RESULTS: Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent). CONCLUSIONS: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.

Integrity signals

Registry

Crossref · 10.1056/nejm200002033420503

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Proposal for Revised Classification of Epilepsies and Epileptic Syndromes: Commission on Classification and Terminology of the International League Against Epilepsy
(1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05316.x · Cited by 5,347
Guidelines for Epidemiologic Studies on Epilepsy
(1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb00433.x · Cited by 1,360
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M., Adam, C., Broglin, D., Arzimanoglou, A. A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,105
Surgery for Seizures
Engel, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603073341008 · Cited by 880
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M. L., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 725
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. W. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 614
Self-citation
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. W. T. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 525
Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 462
Self-citation

Show all 39 references

Research works printed but not linked: 2

Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:517-24.
Wolf P. International classification of the epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:773-7.

Sorted by citations

Items 401–500 of 1,005

Cortical electrode localization from X-rays and simple mapping for electrocorticographic research: The “Location on Cortex” (LOC) package for MATLAB
Miller, K. J., Makeig, S., Hebb, A. O., Rao, R. P. N., den Nijs, M., & Ojemann, J. G. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.01.019 · Cited by 105
The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions
Reddel, S., Putignani, L., & Del Chierico, F. (2019) · Nutrients · doi:10.3390/nu11020373 · Cited by 104
Transcranial direct current stimulation reduces seizure frequency in patients with refractory focal epilepsy: A randomized, double-blind, sham-controlled, and three-arm parallel multicenter study
Yang, D., Wang, Q., Xu, C., Fang, F., Fan, J., Li, L., Du, Q., Zhang, R., Wang, Y., Lin, Y., et al. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.09.006 · Cited by 113
Neurologists' knowledge of and attitudes toward epilepsy surgery
Roberts, J. I., Hrazdil, C. T., Wiebe, S., Sauro, K. M., Vautour, M., Wiebe, N., & Jetté, N. (2014) · Neurology · doi:10.1212/wnl.0000000000001127 · Cited by 104
Patient attitudes about treatments for intractable epilepsy
Swarztrauber, K., Dewar, S. R., & Engel, J. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00687-x · Cited by 104
A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy
Kim, W., Lee, J. H., Yi, J., Cho, Y., Heo, K., Lee, S. H., Kim, S. W., Kim, M., Kim, K. H., Lee, B. I., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328338073a · Cited by 103
ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
Schulz, J., Hartz, A. M. S., & Bauer, B. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000025 · Cited by 118
“Approximately one-third of epilepsy patients do not respond to pharmacological treatment with antiseizure drugs and thus suffer from refractory, drug-resistant epilepsy and uncontrolled seizures (Kwan and Brodie, 2000).”
Background
Current limitations of antiepileptic drug therapy: a conference review
Deckers, C. L. P., Genton, P., Sills, G. J., & Schmidt, D. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00257-7 · Cited by 103
Cognitive and behavioral complications of frontal lobe epilepsy in children: A review of the literature
Braakman, H. M. H., Vaessen, M. J., Hofman, P. A. M., Hall, M. H. J. A. D.-V., Backes, W. H., Vles, J. S. H., & Aldenkamp, A. P. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03057.x · Cited by 103
Safety of repetitive transcranial magnetic stimulation in patients with epilepsy: A systematic review
Pereira, L. S., Müller, V. T., Gomes, M. D. M., Rotenberg, A., & Fregni, F. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.01.015 · Cited by 106
Psychological treatments for people with epilepsy
Michaelis, R., Tang, V. Y. H., Wagner, J. L., Modi, A. C., LaFrance, W. C., Jr., Goldstein, L. H., Lundgren, T., & Reuber, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012081.pub2 · Cited by 101
Early Prediction of Drug Resistant Epilepsy using Claims Data
An, S., Malhotra, K., Dilley, C., Han-Burgess, E., Valdez, J. N., Robertson, J., Clark, C., Westover, M., & Sun, J. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.10.013 · Cited by 88
Sex differences in the epilepsies and associated comorbidities: implications for use and development of pharmacotherapies
Christian, C. A., Reddy, D. S., Maguire, J., & Forcelli, P. A. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.017392 · Cited by 105
A Realistic Seizure Prediction Study Based on Multiclass SVM
Direito, B., Teixeira, C., Sales, F., Castelo-Branco, M. S., & Dourado, A. (2016) · International Journal of Neural Systems · doi:10.1142/s012906571750006x · Cited by 102
Refractory juvenile myoclonic epilepsy: a meta‐analysis of prevalence and risk factors
Stevelink, R., Koeleman, B. P. C., Sander, J. W. A. S., Jansen, F. E., & Braun, K. P. J. (2018) · European Journal of Neurology · doi:10.1111/ene.13811 · Cited by 101
Prophylactic antiepileptic treatment in Sturge–Weber disease
Ville, D. M., Enjolras, O., Chiron, C., & Dulac, O. (2002) · Seizure · doi:10.1053/seiz.2001.0629 · Cited by 101
Epilepsy surgery: eligibility criteria and presurgical evaluation
Ryvlin, P., & Rheims, S. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.1/pryvlin · Cited by 101
Autonomic epileptic seizures, autonomic effects of seizures, and SUDEP
Moseley, B. D., Bateman, L. M., Millichap, J. G., Wirrell, E. C., & PANAYIOTOPOULOS, C. P. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.08.020 · Cited by 100
Integrating artificial intelligence with real-time intracranial EEG monitoring to automate interictal identification of seizure onset zones in focal epilepsy
Varatharajah, Y., Berry, B. M., Cimbálník, J., Křemen, V., Gompel, J. J. V., Stead, M., Brinkmann, B. H., Iyer, R. K., & Worrell, G. A. (2018) · Journal of Neural Engineering · doi:10.1088/1741-2552/aac960 · Cited by 103
Impact of predictive, preventive and precision medicine strategies in epilepsy
Nabbout, R., & Kuchenbuch, M. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0409-4 · Cited by 101
Forecasting Seizure Likelihood With Wearable Technology
Stirling, R. E., Grayden, D. B., D'Souza, W. J., Cook, M. J., Nurse, E. S., Freestone, D. R., Payne, D. E., Brinkmann, B. H., Attia, T. P., Viana, P. F., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.704060 · Cited by 96
Accuracy Enhancement of Epileptic Seizure Detection: A Deep Learning Approach with Hardware Realization of STFT
Beeraka, S. M., Kumar, A., Sameer, M., Ghosh, S. P., & Gupta, B. (2021) · Circuits Systems and Signal Processing · doi:10.1007/s00034-021-01789-4 · Cited by 104
Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy
Renfroe, J. B., & Wheless, J. W. (2002) · Neurology · doi:10.1212/wnl.59.6_suppl_4.s26 · Cited by 100
A review of the pharmacology and clinical efficacy of brivaracetam
Klein, P., Diaz, A., Gasalla, T., & Whitesides, J. (2018) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s114072 · Cited by 99
Chemogenetic silencing of hippocampal neurons suppresses epileptic neural circuits
Zhou, Q., Nemes, A. D., Lee, D., Ro, E. J., Zhang, J., Nowacki, A. S., Dymecki, S. M., Najm, I., & Suh, H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95731 · Cited by 97
Cannabidiol in the Treatment of Epilepsy
von Wrede, R. D., Helmstaedter, C., & Surges, R. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01003-y · Cited by 105
Development and Validation of a Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed Epilepsy
Hakeem, H., Feng, W. S., Chen, Z. Z., Choong, J., Brodie, M. J., Fong, S., Lim, K. S., Wu, J., Wang, X., Lawn, N. D., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.2514 · Cited by 105
Self-citation
Surgical treatment of medically refractory epilepsy in childhood
Snead, O. C. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00204-2 · Cited by 99
The methylation hypothesis of pharmacoresistance in epilepsy
Kobow, K., El‐Osta, A., & Blümcke, I. (2013) · Epilepsia · doi:10.1111/epi.12183 · Cited by 97
Cost‐effectiveness of First‐line Antiepileptic Drug Treatments in the Developing World: A Population‐level Analysis
Chisholm, D., & WHO‐CHOICE (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.52704.x · Cited by 98
Roadmap for a competency‐based educational curriculum in epileptology: report of the Epilepsy Education Task Force of the International League Against Epilepsy
Blümcke, I., Arzimanoglou, A. A., Beniczky, S., Wiebe, S., & the EpiEd Task Force (2019) · Epileptic Disorders · doi:10.1684/epd.2019.1039 · Cited by 98
Ketogenic Diet
Dhamija, R., Eckert, S., & Wirrell, E. C. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013676 · Cited by 97
Shortcomings in the current treatment of epilepsy
Eadie, M. J. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.129 · Cited by 97
Pharmacokinetics and Drug Interactions with Zonisamide
Sills, G. J., & Brodie, M. J. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00983.x · Cited by 97
Self-citation
Comparing Noninvasive Dense Array and Intracranial Electroencephalography for Localization of Seizures
Holmes, M. D., Tucker, D. M., Quiring, J., Hakimian, S., Miller, J. W., & Ojemann, J. G. (2010) · Neurosurgery · doi:10.1227/01.neu.0000363721.06177.07 · Cited by 97
Mitochondrial dysfunction and oxidative stress in seizure-induced neuronal cell death.
Chuang, Y. (2010) · PubMed · Cited by 97
Adjunctive cenobamate in highly active and ultra‐refractory focal epilepsy: A “real‐world” retrospective study
Peña‐Ceballos, J., Moloney, P. B., Munteanu, T., Doyle, M. G., Colleran, N., Liggan, B., Breen, A., Murphy, S. A., Naggar, H. E., Widdess‐Walsh, P., et al. (2023) · Epilepsia · doi:10.1111/epi.17549 · Cited by 96
Advantages of Repeated Low Dose against Single High Dose of Kainate in C57BL/6J Mouse Model of Status Epilepticus: Behavioral and Electroencephalographic Studies
Tse, K., Puttachary, S., Beamer, E. H., Sills, G. J., & Thippeswamy, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096622 · Cited by 96
Racial/ethnic disparities in the treatment of epilepsy: What do we know? What do we need to know?
Szaflarski, M., Szaflarski, J. P., Privitera, M., Ficker, D. M., & Horner, R. D. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.05.011 · Cited by 96
Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy
Widjaja, E., Li, B., Schinkel, C. D., Ritchie, L. M. P., Weaver, J. C., Snead, O. C., Rutka, J. T., & Coyte, P. C. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.01.005 · Cited by 96
Predicting seizure control: Cortical excitability and antiepileptic medication
Badawy, R. A. B., Macdonell, R. A. L., Berkovic, S. F., Newton, M. R., & Jackson, G. D. (2009) · Annals of Neurology · doi:10.1002/ana.21806 · Cited by 96
The challenges of treating epilepsy with 25 antiepileptic drugs
Santulli, L., Coppola, A., Balestrini, S., & Striano, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.016 · Cited by 97
Seizures and Epilepsy
Johnson, E. L. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.10.002 · Cited by 105
Barriers toward epilepsy surgery. A survey among practicing neurologists
Erba, G., Moja, L., Beghi, E., Messina, P., & Pupillo, E. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03282.x · Cited by 95
Low threshold T ‐type calcium channels as targets for novel epilepsy treatments
Powell, K. L., Cain, S. M., Snutch, T. P., & O'Brien, T. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12205 · Cited by 98
Individual state driving restrictions for people with epilepsy in the US
Krauss, G. L., Ampaw, L., & Krumholz, A. (2001) · Neurology · doi:10.1212/wnl.57.10.1780 · Cited by 95
Cortical feature analysis and machine learning improves detection of “MRI-negative” focal cortical dysplasia
Ahmed, B., Brodley, C. E., Blackmon, K., Kuzniecky, R., Barash, G., Carlson, C., Quinn, B. T., Doyle, W., French, J. A., Devinsky, O., et al. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.055 · Cited by 95
P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice
Sills, G. J., Kwan, P., Butler, E., de Lange, E. C. M., van den Berg, D., & Brodie, M. J. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00511-5 · Cited by 95
Self-citation
Epigenetics in epilepsy
Kobow, K., & Blümcke, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.012 · Cited by 100
Collateral brain damage, a potential source of cognitive impairment after selective surgery for control of mesial temporal lobe epilepsy.
Helmstaedter, C., Roost, D. V., Clusmann, H., Urbach, H., Elger, C. E., & Schramm, J. (2004) · PubMed Central · Cited by 94
Consensus guidelines into the management of epilepsy in adults with an intellectual disability
Kerr, M. P., Scheepers, M., Arvio, M., Beavis, J. M., Brandt, C., Brown, S., Huber, B., Iivanainen, M., Louisse, A., Martin, P., et al. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01182.x · Cited by 94
Quality of life in medication-resistant epilepsy: The effects of patient’s age, age at seizure onset, and disease duration
Szaflarski, M., Meckler, J. M., Privitera, M., & Szaflarski, J. P. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.01.001 · Cited by 94
Novel Mechanisms of Action of Three Antiepileptic Drugs, Vigabatrin, Tiagabine, and Topiramate
Ängehagen, M., Ben‐Menachem, E., Rönnbäck, L., & Hansson, E. (2003) · Neurochemical Research · doi:10.1023/a:1022393604014 · Cited by 94
Anticonvulsant mechanisms of piperine, a piperidine alkaloid
Mishra, A., Punia, J. K., Bladen, C., Zamponi, G. W., & Goel, R. K. (2015) · Channels · doi:10.1080/19336950.2015.1092836 · Cited by 94
Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents
Mohammadi‐Khanaposhtani, M., Shabani, M., Faizi, M., Aghaei, I., Jahani, R., Sharafi, Z., Zafarghandi, N. S., Mahdavi, M. R., Akbarzadeh, T., Emami, S., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.054 · Cited by 94
Diffusion tensor imaging in refractory epilepsy
Rugg‐Gunn, F. J., Eriksson, S. H., Symms, M. R., Barker, G. J., Thom, M., Harkness, W. F. J., & Duncan, J. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08615-4 · Cited by 94
Antiepileptic Drugs—A Review
Sankaraneni, R. M., & Lachhwani, D. (2015) · Pediatric Annals · doi:10.3928/00904481-20150203-10 · Cited by 93
Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy
Gauthier, A. C., & Mattson, R. H. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12399 · Cited by 93
Cellular and network mechanisms of electrographic seizures
Bazhenov, M., Timofeev, I., Frӧhlich, F., & B, T. J. S. A. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2008.07.005 · Cited by 93
Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary
Gloss, D., Pargeon, K., Pack, A. M., Varma, J., French, J. A., Tolchin, B. D., Dlugos, D. J., Mikati, M. A., & Harden, C. (2021) · Neurology · doi:10.1212/wnl.0000000000012944 · Cited by 93
“The purpose of prescribing an antiseizure medication (ASM) is to render patients with epilepsy seizure-free, a task that is accomplished approximately two-thirds of the time.(5,6) When seizure freedom is achieved, there is the inevitable question of if and when ASMs should be weaned.”
Background
Artificial intelligence in epilepsy — applications and pathways to the clinic
Lucas, A., Revell, A. Y., & Davis, K. A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00965-9 · Cited by 93
“For two-thirds of people with epilepsy, their condition will respond to anti-seizure drugs, but one-third will remain with uncontrolled seizures 1 .”
Striking Differences in Individual Anticonvulsant Response to Phenobarbital in Rats with Spontaneous Seizures after Status Epilepticus
Brandt, C., Volk, H. A., & Löscher, W. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.16904.x · Cited by 93
Refractory seizures: Try additional antiepileptic drugs (after two have failed) or go directly to early surgery evaluation?
Kwan, P., & Sperling, M. R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02237.x · Cited by 93
Self-citation
Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy
Ufer, M., Mosyagin, I., Muhle, H., Jacobsen, T., Haenisch, S., Häsler, R., Faltraco, F., Remmler, C., von Spiczak, S., Kroemer, H. K., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328329940b · Cited by 93
The clinical impact of new antiepileptic drugs after a decade of use in epilepsy
Schmidt, D. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00065-7 · Cited by 93
Less is more
Gross, R. E., Mahmoudi, B., & Riley, J. P. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000176 · Cited by 92
Outcomes After Anterior or Complete Corpus Callosotomy in Children
Kasasbeh, A. S., Smyth, M. D., Steger-May, K., Jalilian, L., Bertrand, M. E., & Limbrick, D. D. (2013) · Neurosurgery · doi:10.1227/neu.0000000000000197 · Cited by 92
In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein
Zhang, C., Zuo, Z., Kwan, P., & Baum, L. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03140.x · Cited by 93
Self-citation
ABCC2 Polymorphisms and Haplotype are Associated with Drug Resistance in Chinese Epileptic Patients
Qu, J., Zhou, B., Yin, J., Xu, X., Zhao, Y., Lei, G., Tang, Q., Zhou, H., & Liu, Z. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00336.x · Cited by 92
Pregabalin: A new antiepileptic drug for refractory epilepsy
Hamandi, K., & Sander, J. W. A. S. (2006) · Seizure · doi:10.1016/j.seizure.2005.11.005 · Cited by 92
EPILAB: A software package for studies on the prediction of epileptic seizures
Teixeira, C., Direito, B., Feldwisch‐Drentrup, H., Valderrama, M., Costa, R. P., Alvarado‐Rojas, C., Nikolopoulos, S., Quyen, M. L. V., Timmer, J., Schelter, B. O., et al. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.07.002 · Cited by 95
Exploring the time–frequency content of high frequency oscillations for automated identification of seizure onset zone in epilepsy
Liu, S., Sha, Z., Sencer, A., Aydöseli, A., Bebek, N., Abosch, A., Henry, T. R., Gürses, C., & Ince, N. F. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/2/026026 · Cited by 92
Drug Treatment of Epilepsy: When Does It Fail and How to Optimize Its Use?
Kwan, P., & Brodie, M. J. (2004) · CNS Spectrums · doi:10.1017/s1092852900008476 · Cited by 92
Self-citation
Effects of religiosity and religious coping on medication adherence and quality of life among people with epilepsy
Lin, C., Saffari, M., Koenig, H. G., & Pakpour, A. H. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.10.008 · Cited by 91
Electromagnetic source imaging in presurgical workup of patients with epilepsy
Duez, L., Tankişi, H., Hansen, P. O., Sidenius, P., Sabers, A., Pinborg, L. H., Fabricius, M. E., Rásonyi, G., Rubboli, G., Pedersen, B., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000006877 · Cited by 91
Management and long-term outcome in patients presenting with ictal asystole or bradycardia
Strzelczyk, A., Cenusa, M., Bauer, S., Hamer, H. M., Mothersill, I. W., Grünwald, T., Hillenbrand, B., Ebner, A., Steinhoff, B. J., Krämer, G., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02961.x · Cited by 91
A postnatal peak in microglial development in the mouse hippocampus is correlated with heightened sensitivity to seizure triggers
Kim, I., Mlsna, L. M., Yoon, S., Le, B., Yu, S., Xu, D., & Koh, S. (2015) · Brain and Behavior · doi:10.1002/brb3.403 · Cited by 91
Ketone Bodies as Anti-Seizure Agents
Simeone, T. A., Simeone, K. A., & Rho, J. M. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2253-5 · Cited by 91
Pregabalin As Adjunctive Therapy for Partial Seizures
Brodie, M. J. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.455004.x · Cited by 91
Self-citation
The value of magnetoencephalography for seizure-onset zone localization in magnetic resonance imaging-negative partial epilepsy
Jung, J., Bouet, R., Delpuech, C., Ryvlin, P., Isnard, J., Guénot, M., Bertrand, O., Hammers, A., & Mauguı̀ere, F. (2013) · Brain · doi:10.1093/brain/awt213 · Cited by 90
An optimal strategy for epilepsy surgery: Disruption of the rich-club?
Lopes, M. A., Richardson, M. P., Abela, E., Rummel, C., Schindler, K. A., Goodfellow, M., & Terry, J. R. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005637 · Cited by 88
Deep-learning for seizure forecasting in canines with epilepsy
Nejedlý, P., Křemen, V., Sladky, V., Nasseri, M., Guragain, H., Klimeš, P., Cimbálník, J., Varatharajah, Y., Brinkmann, B. H., & Worrell, G. A. (2019) · Journal of Neural Engineering · doi:10.1088/1741-2552/ab172d · Cited by 93
Antiepileptic drug monotherapy versus polytherapy
Stephen, L. J., & Brodie, M. J. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328350ba68 · Cited by 90
Self-citation
Is Refractory Epilepsy Preventable?
Arroyo, S., Brodie, M. J., AVANZINI, G., Baumgartner, C., Chiron, C., Dulac, O., French, J. A., & Serratosa, J. M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.38501.x · Cited by 90
Self-citation
LONG-TERM SEIZURE CONTROL AFTER RESECTION OF SUPRATENTORIAL CAVERNOMAS
Stavrou, I., Baumgartner, C., Frischer, J. M., Trattnig, S., & Knosp, E. (2008) · Neurosurgery · doi:10.1227/01.neu.0000327881.72964.6e · Cited by 90
Statin use and risk of epilepsy
Etminan, M., Samii, A., & Brophy, J. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f96253 · Cited by 90
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients
Hammers, A., Koepp, M. J., Richardson, M. P., Hurlemann, R., Brooks, D. J., & Duncan, J. S. (2003) · Brain · doi:10.1093/brain/awg138 · Cited by 90
Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain
Kwon, Y. S., Pineda, E., Auvin, S., Shin, D. H., Mazarati, A. M., & Sankar, R. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-30 · Cited by 94
SEEG assistant: a 3DSlicer extension to support epilepsy surgery
Narizzano, M., Arnulfo, G., Ricci, S., Toselli, B., Tisdall, M. M., Canessa, A., Fato, M., & Cardinale, F. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1545-8 · Cited by 94
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
Rodríguez-Muñoz, M., Sánchez‐Blázquez, P., Merlos, M., & Garzón-Niño, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10095 · Cited by 87
Mind the gap: Multiple events and lengthy delays before presentation with a “first seizure”
Firkin, A. L., Marco, D. J. T., Saya, S., Newton, M. R., O'Brien, T. J., Berkovic, S. F., & McIntosh, A. M. (2015) · Epilepsia · doi:10.1111/epi.13127 · Cited by 89
Magnetoencephalography adds to the surgical evaluation process
Stefan, H., Rampp, S., & Knowlton, R. C. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.09.011 · Cited by 88
Seizure Relapse and Development of Drug Resistance Following Long-term Seizure Remission
Schiller, Y. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.211 · Cited by 88
Personalized medicine approaches in epilepsy
Walker, L. E., Mirza, N., Yip, V. L. M., Marson, A. G., & Pirmohamed, M. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12322 · Cited by 89
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial
Kwan, P., Brodie, M. J., Kälviäinen, R. K., Yurkewicz, L., Weaver, J., & Knapp, L. E. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70154-5 · Cited by 88
Self-citation
Levetiracetam safety profiles and tolerability in epilepsy patients
Briggs, D. E., & French, J. A. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.5.415 · Cited by 88
Neuronal and Glial Expression of the Multidrug Resistance Gene Product in an Experimental Epilepsy Model
Lazarowski, A., Ramos, A. J., Rivello, H. G., Brusco, A., & Girardi, E. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000012726.43842.d2 · Cited by 88
Vagus nerve stimulation therapy in patients younger than 18 years
Wheless, J. W., & Maggio, V. (2002) · Neurology · doi:10.1212/wnl.59.6_suppl_4.s21 · Cited by 88
4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy
Hedrich, U. B. S., Lauxmann, S., Wolff, M., Synofzik, M., Bast, T., Binelli, A., Serratosa, J. M., Martínez-Ulloa, P., Allen, N. M., King, M. D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4957 · Cited by 87
Emerging roles of Na+/H+ exchangers in epilepsy and developmental brain disorders
Zhao, H., Carney, K. E., Falgoust, L., Pan, J. W., Sun, D., & Zhang, Z. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.02.002 · Cited by 89

Authors: Kwan, P., & Brodie, M. J.
Affiliations: Western Infirmary (GB)
ORCID: Kwan, Patrick
Brodie, Martin J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-02-03
Volume: 342
Issue: 5
Pages: 314-319
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200002033420503
OpenAlex: W1974809694
Cited by: 5,204
References: 39
Citations by year: 2026: 225 · 2025: 241 · 2024: 259 · 2023: 275 · 2022: 269 · 2021: 328 · 2020: 348 · 2019: 253 · 2018: 270 · 2017: 228 · 2016: 249 · 2015: 230 · 2014: 205 · 2013: 233 · 2012: 248
FWCI: 55.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
CRC Press eBooks (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords: drug-resistant epilepsy, antiepileptic drugs, seizure control, newly diagnosed epilepsy, idiopathic epilepsy, symptomatic epilepsy, cryptogenic epilepsy, seizure frequency, predictors of treatment failure, adverse drug reactions, polypharmacy
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Anticonvulsants, Child, Epilepsy, Female, Humans, Male, Middle Aged, Prospective Studies, Remission Induction, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early Identification of Refractory Epilepsy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks